By joining Bio-Techne, you’ll join a company with a powerful and positive purpose of enabling cutting-edge research in Life Sciences and Clinical Diagnostics. Bio-Techne, and all of its brands, provides tools for researchers to further treat and prevent disease worldwide.
Pay Range:
$133,300.00 - $219,100.00Position Summary
The Senior Manager, Product Management – IHC Application is responsible for defining and leading the global portfolio strategy for antibodies supporting tissue-based workflows, including Immunohistochemistry (IHC), chromogenic and fluorescent tissue imaging, and translational pathology research.
This role owns the scientific, validation, and portfolio strategy that establishes R&D Systems as the authority in tissue biology, ensuring antibodies deliver superior tissue specificity, reproducibility, and disease relevance.
As the portfolio leader for tissue imaging antibodies, this individual defines innovation priorities, validation standards, and portfolio investments, while guiding execution through Product Management resources supporting spatial biology and digital experience.
The role partners closely with R&D, Applications, and Commercial teams to ensure the tissue antibody portfolio delivers scientific differentiation and sustainable growth.
This position reports to the Head of Target Analysis Business Unit and is based on-site in Minneapolis, MN.
Key Responsibilities
Franchise & Portfolio Strategy
- Define and lead the global portfolio strategy for tissue imaging antibodies across IHC and tissue biology workflows.
- Establish long-term portfolio vision aligned to disease research, translational pathology, and biomarker discovery trends.
- Translate strategy into roadmap priorities, investment allocation, and lifecycle management frameworks.
- Lead portfolio segmentation across discovery, translational, and clinical research applications.
Validation & Scientific Differentiation
- Establish validation frameworks and performance standards for tissue imaging antibodies.
- Define criteria for tissue specificity, biomarker selectivity, and reproducibility.
- Prioritize validation investments supporting portfolio differentiation and customer confidence.
Innovation & Portfolio Expansion
- Identify whitespace opportunities across biomarkers, pathways, and disease segments.
- Guide innovation investments including proprietary clone development and recombinant conversion strategies.
- Define disease-focused panel strategies across oncology, immunology, neuroscience, and inflammation biology.
Business Performance Ownership
- Own revenue growth, portfolio mix, and margin performance across tissue imaging antibodies.
- Define KPIs spanning adoption, validation coverage, and disease panel penetration.
- Monitor portfolio risks, gaps, and growth opportunities and drive corrective action.
Go-To-Market & Commercial Execution
- Own Tissue Biology Antibody portfolio GTM success across all channels (digital, direct sales, partners).
- Define pricing strategy, value positioning, and promotional priorities aligned to customer decision drivers.
- Support customer adoption through application notes, and scientific storytelling.
Required Qualifications
- Master’s degree in Life Sciences required; PhD strongly preferred.
- Minimum 5 years of Product Management or portfolio leadership experience in research reagents or antibodies.
- Deep expertise in tissue imaging workflows (IHC, IF, pathology, tissue biology).
- Experience leading Product Management resources in a matrixed environment (direct or indirect reporting).
- Demonstrated success leading portfolio strategy and innovation roadmaps.
- Experience influencing R&D investment and cross-functional priorities.
- Strong analytical and strategic planning capabilities
Why Join Bio-Techne:
- We offer competitive insurance benefits starting on day one: medical, dental, vision, life, short-term disability, long-term disability, pet, and legal and ID shield.
- We invest in our employees’ financial futures through 401k plans, an employee stock purchase plan (ESPP), Health Saving Account (HSA), Flexible Spending Account (FSA), and Dependent Care FSA.
- We empower our employees develop their careers through mentorship, promotional opportunities, training and development, tuition reimbursement, internship programs, and more.
- We offer employee resource groups, volunteer paid time off, employee events, and charity drives to build a culture of caring and belonging.
- We offer an accrued leave policy with paid holidays, paid time off, and paid parental leave.
- We foster a culture of empowerment and innovation, where employees feel valued and encouraged to bring their new ideas to the table.
Bio-Techne is an E-Verify Employer in the United States.
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
To protect the interests of all, Bio-Techne will not accept unsolicited resumes from any source other than a candidate application. Any unsolicited resumes sent to Bio-Techne will be considered Bio-Techne property.
Top Skills
What We Do
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment. Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEM and clinical customers. Bio-Techne’s genomic tools include advanced tissue-based in situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand, as well as a portfolio of clinical molecular diagnostic oncology assays including the ExoDx®Prostate (IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne’s Diagnostics and Genomics Segment. Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $714 million in net sales in fiscal 2019 and has over 2,200 employees worldwide.
